HAV-IgM (Anti-HAV ) Reagent – Jaj International
Description
Hepatitis A virus or HAV-IgM Anti-HAV Reagent rapid test is used for the detection of immunoglobulin G(IgM) and of past and present infections respectively as shown above picture. Hepatitis A is an acute, usually self-limiting disease of the liver caused by HAV. It is transmitted from person to person, primarily by the face-oral route.
The incidence of hepatitis A is closely related to socioeconomic development, and seroepidemiological studies show that the prevalence of anti-HAV antibodies in the general population varies from 15% to close to 100% in different parts of the world. This HAV IgG/IgM test is a simple, visual qualitative test that detects Hepatitis A Virus antibodies in human serum or plasma.
The test is based on Immunochromatography and can give a result within 15 minutes. It indicates protective immunity by detecting HAV IgG titers ≥70 mIU/mL. High confidence as it is traceable to the 2nd WHO International Standard for HAV and IgM is in agreement with the market-leading Elisa Test: Sensitivity: 94.8%; Specificity: 96.7% (Ctkbiotech).A small sample volume (5 µL) enables multiple tests on the same specimen without having to re-draw the patient. Initial patient care action can begin during the patient’s visit as test results are available in 15 minutes.
Easily transported, and can be stored for 24 months at 2-30°C. This test provides only a preliminary test result. Therefore, isolation of the virus, PCR and RT- PCR more specific alternative diagnostic methods must be used in order to obtain a confirmation of Hepatitis A virus infection.
Reviews
There are no reviews yet.